Skip to Content

I4338 5 mg (Terazosin 5 mg)

Pill imprint I4338 5 mg has been identified as Terazosin hydrochloride 5 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Terazosin hydrochloride 5 mg I4338 5 mg
Terazosin hydrochloride 5 mg I4338 5 mg
Terazosin hydrochloride
Imprint:
I4338 5 mg
Strength:
5 mg
Color:
Orange & White
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-4338
Inactive Ingredients:
corn starch
crospovidone
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
lactose monohydrate
magnesium stearate
propylene glycol
shellac
ferrosoferric oxide
magnesium silicate
titanium dioxide
aluminum oxide

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide